Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
There are three GLP-1 FDA decisions expected in early-mid 2026 Eli Lillys Mounjaro with a new indication to reduce the risk of major adverse cardiovascular events (MACE) in patients with T2DM Eli Lillys oral once-daily orforglipron for weight loss Novo Nordisks higher dose (7.2 mg) injectable once-weekly Wegovy for weight loss Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics talented team of clinical experts actively monitors this emerging landscape
BPC-157 may help promote healing at the cell level Vascular Health : Research into blood vessel formation, circulation, and heart health conditions Brain Protection : Early studies on nerve and brain tissue protection
Geopolitical factors, such as trade agreements, intellectual property rights, and the stability of international supply chains for pharmaceutical ingredients, can also impact the manufacturing and distribution of GLP-1 receptor agonists globally
Bhojraj specializes in cardiometabolic optimization, mitochondrial health, redox biology, and longevity-focused cardiovascular prevention
